Drugs like DPP-IV inhibitors, GLP-1 agonists, FXR agonists, and SGLT2 inhibitors might be useful in the treatment of NAFLD. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.